Cleft Palate
Conditions
Keywords
Cleft Palate Surgery, Antibiotic treatment
Brief summary
Cleft Lip and Palate surgical repair is one of the most common procedures performed by Plastic and Reconstructive Surgeons in the World. With this in mind, it is curious that no consensus exists regarding the usage of postoperative antibiotics or the effects this might have on wound complications such as cellulitis, dehiscence, or fistula formation. The surgical bed in cleft lip/palate repair is known to harbor a myriad of pathological organisms, indeed the human bite is one of the more clinically and microbiologically significant injuries to treat. This research study is to elucidate the role, if any, that prophylactic antibiotics have in the prevention of complications post cleft palate (CP) and VPI repair and potentially establish a new paradigm of care.
Detailed description
This will be a randomized prospective research study. Participants who will undergo an elective CP or VPI surgery will be randomized to receive either 1) antibiotics or 2) nothing postoperatively. All participants will be evaluated for infection, fistula formation, and dehiscence upon discharge and at 30-day follow-up based on standards of care.
Interventions
DRUGAmoxicillin
Amoxicillin will be given as: 7 days, 20mg/kg orally every 6 hours to a maximum of 1.8g/day for a 7-day period.
Sponsors
University of Florida
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
1 Months to 60 Years
Healthy volunteers
No
Inclusion criteria
1. Ages 1 month to 60 years 2. Subjects undergoing independently scheduled elective Cleft Palate of VPI repair 3. Do not meet any
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Infection rates between the groups | 30 days | Analysis of infection is based on a 7 point scale to allow for broadened data but can be evaluated in a binary fashion for ≥ 4 indicating infection and \<4 as no infection. A χ2 test and Fisher's exact test for p\<0.05 will be used to determine significance of the difference in complication (cellulitis and upper respiratory infection) rates between the two groups. |
| Dehiscence and fistula formation between the groups | 30 days | Both dehiscence and fistula formation will also be recorded as a binary present/not present data point to determine the significance of the difference in complication rates between the groups. |
Countries
United States
Outcome results
None listed